The Carlyle Group (NASDAQ:CG) is in advanced discussions to invest in Resonetics, LLC according to people familiar with the matter. Carlyle is in talks to buy half of Resonetics in a deal that will value the medical-device manufacturing company at about $2.3 billion, including debt, the people said, asking not be identified because the matter is private.